Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LGND
LGND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LGND News
Ligand Pharmaceuticals Prices $625M Convertible Notes Offering
Jun 23 2026
seekingalpha
Ligand Pharmaceuticals Prices $625 Million Convertible Note Offering
Jun 23 2026
NASDAQ.COM
Ligand Pharmaceuticals Raises $625 Million in Convertible Notes Offering
Jun 23 2026
Newsfilter
Mixed Market Close: Tech Stocks Decline Amid Leadership Changes
Jun 22 2026
NASDAQ.COM
Mixed U.S. Stock Performance with Tech Stocks Leading Declines
Jun 22 2026
NASDAQ.COM
U.S. Stocks Edge Up, Nasdaq Hits 2.5-Week High
Jun 22 2026
NASDAQ.COM
Ligand Pharmaceuticals Plans $550M Convertible Notes Offering
Jun 22 2026
seekingalpha
Ligand Pharmaceuticals Director Sells Shares
Jun 14 2026
Fool
Kozarich Sells Shares of Ligand Pharmaceuticals
Jun 14 2026
NASDAQ.COM
Ligand Pharmaceuticals to Host Investor Day in New York City
Jun 10 2026
Newsfilter
Ligand Executive Sells $1.14 Million in Stock Following Options Exercise
Jun 07 2026
Fool
Ligand Executive Sells Shares to Supplement Income
Jun 07 2026
NASDAQ.COM
Ligand Executive Sells 5,000 Shares for $1.1 Million
Jun 07 2026
Yahoo Finance
Legend Biotech Reports Promising Early Results for LB2501 CAR-T Therapy
Jun 02 2026
seekingalpha
Ligand Pharmaceuticals Q1 Earnings Announcement Scheduled
May 06 2026
seekingalpha
Investigation Alerts for Multiple Company Mergers
May 05 2026
Globenewswire
Show More News
